SomnoMed Limited (ASX:SOM)
0.6600
-0.0300 (-4.35%)
Feb 25, 2026, 3:22 PM AEST
SomnoMed Revenue
In the fiscal year ending June 30, 2025, SomnoMed had annual revenue of 111.49M AUD with 21.65% growth. SomnoMed had revenue of 57.78M in the half year ending June 30, 2025, with 32.36% growth.
Revenue
111.49M
Revenue Growth
+21.65%
P/S Ratio
1.29
Revenue / Employee
371.64K
Employees
300
Market Cap
144.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 111.49M | 19.84M | 21.65% |
| Jun 30, 2024 | 91.65M | 8.03M | 9.61% |
| Jun 30, 2023 | 83.62M | 11.04M | 15.20% |
| Jun 30, 2022 | 72.58M | 9.87M | 15.75% |
| Jun 30, 2021 | 62.71M | 5.41M | 9.44% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PolyNovo | 139.49M |
| Aroa Biosurgery | 79.26M |
| Compumedics | 51.04M |
| Nova Eye Medical | 29.27M |
| CleanSpace Holdings | 19.76M |
| Lumos Diagnostics Holdings | 18.91M |
| Micro-X | 13.05M |
| ImpediMed | 12.72M |